Term Paper on "Occupational Health and Safety and Lighting"

Home > Topics > Disease & Injury My Account

Term Paper 12 pages (3788 words) Sources: 20 Style: Harvard

[EXCERPT] . . . .

Risk and Hazard Factors of Bright Blue Light

The public is constantly being inundated by advertising that states that the intensity and range of colors offered by lamps that replicate sunshine and daylight are necessary for best vision and visual health. Simultaneously, the public is admonished by those in the medical field to wear blue-blocking, UV-protective sunglasses outdoors. This has necessarily left questions which need answered concerning these matters in relation to whom the public should believe and how light can damage the retinas of the individual as well as what the differences are between fluorescent, halogen, neodymium, and regular incandescent light bulbs.

The aim of the following proposal for research is to examine the risk and hazard factors of bright blue light in the workplace and to further compare the use of green light in the work place and examine the safety issues relating to green light use.

OBJECTIVES

The objective of this research is to examine the hazards and risks associated with the use of blue light in the work place and the various factors such as aging that result in different effects for different individuals who are exposed to bright blue light. As well, this work will examine the use of green light in the workplace and the safety issues relating to the use of green light. This work intends to examine as well the fact that blue light marketers inform the public that lamps with 'enhanced' UV will ensure better health.

HYPOTHESIS

The hypothesis of this work is one which holds that green light is safer for use in the workplace than blue light and seeks

Continue scrolling to

download full paper ⤓

to answer the question of why the public is continually informed that blue light or UV light when is enhanced serves to enhance the health of the individual.

RATIONALE

This study intends to sort through the plethora of conflicting information in this area of study and to attempt to determine the facts associated with blue lighting safety in the workplace and to make a comparison of green lighting use in regards to safety and health issues.

METHODOLOGY

The methodology of this study is one of a qualitative nature and will be conducted through an extensive review of literature in this area of study. This study is therefore, interpretive in nature is a study that will be conducted through a synthesis of the research findings in this area of study.

LITERATURE REVIEW

The work of Lack, Bramwell, Wright and Kemp entitled: "Morning Blue Light Can Advance the Melatonin Rhythm in Mild Delayed Sleep Phase Syndrome" reports an investigation into the "effectiveness of morning blue light in advancing the sleep and melatonin rhythm of individuals with mild delayed sleep phase syndrome." (2007) the study was conducted through random allocation of the participants (n=18) to a light or control group. Reported is a gradually advance of wake-up times to 06:00 hours over the course of a week. The blue light group is stated to have shown "significant 2.53-h advance of dim light melatonin onset, compared to no change in the control group. However, neither group had a significant advance of sleep times following treatment." (Lack, Bramwell, Wright, and Kemp, 2007)

Sunnex Biotechnologies reports, in the work entitled: "Risk Factors of Blue and Bright Light Therapy" that photoretinitis, also known as "light-induced photochemical damage to the eye, is related to the 'blue light hazard' a term which begins to suggest why the prospect of blue light therapy dramatically raises the risk of light-induced retinal damage from light therapy." (2008) it is stated that there are commercial standards used for assessing the "acute risk to photoreceptor cells from high intensity white light sources for a 'standard observer', but individual susceptibility to blue light damage is so variable that these standards cannot presume to eliminate a person's risk of acute damage from a blue light therapy device, let alone the long-term risk that repeated exposure may contribute towards the development of age-related macular degeneration (AMD) to which these standards do not apply." (Sunnex Biotechnologies, 2008) Additionally stated is that "the image of a light source on a small area of the retina with the intensity necessary to be chronobiologically effective may cause a hazard to the retina, even if the same number of photons diffused over a larger portion of the retina do not." (Sunnex Biotechnologies, 2008) the factors identified as those which provide indication as to why blue light therapy presents a "significant, inestimable risk to the retina not accounted for by commercial assessments of blue light hazard" are those as follows: (1) the variability of individual susceptibility to AMD, as well as to the variability of the transmissibility of blue light through the eye to the retina; the susceptibility for AMD varies greatly with the individual, and the conditions by which normal retinal deterioration from aging becomes the pathological deterioration known as AMD are not yet established. Contributing to the variability of susceptibility amongst individuals are genetic factors such as skin color, macular pigment density, lifestyle factors such as the amount of fat, lutein, antioxidant vitamins and zinc in the diet, history of smoking, outdoor activity, and other environmental factors such as previous levels of light exposure." (Sunnex Biotechnologies, 2008) There is stated to be a problem in the determination of the intensity of blue light that would be necessary for effective therapy. Stated is: "The proportion of blue light reaching the eye that is transmitted to the retina is highly variable from one individual to another." (Sunnex Biotechnologies, 2008) the yellowing of the lens of the eye, which is related to aging and resulting in a change in the lens, cornea and vitreous "...substantially decrease the amount of blue wavelengths reaching the retina by middle age." (Sunnex Biotechnologies, 2008) This means there would be a need for a substantial increase in the intensity of blue light for effective treatment n older people. However, it is noted that as one advances in age the blue light absorbing macular pigment which provides protection to the small region of the retina experiences a decrease. As well, the MP density is greatly variable among individuals and is related to the individual's genetic, history of light exposure and factors related to individual lifestyle. MP density is also determined by the diet of the individuals and experiences variability daily. Due to these reasons: "...it would be impossible to calibrate a level of blue light that is both effective and safe for a wide range of individuals. Higher levels of exposure to blue light would be necessary to stimulate chronobiologically significant pathways in individuals in whom the ocular media prevents most blue light wavelengths from reaching the retina. But a blue light therapy device that provided sufficient intensity for effective stimulation of this middle-aged or older individual whose ocular media screens our most of the blue light could pose a significant risk of creating photo-oxidative damage in a person who has high transmissibility of blue light, such a younger adult or a person who has had cataract surgery, or a person is pre-disposed to retinal disease." (Sunnex Biotechnologies, 2008) (2) Risks of blue light therapy in the elderly, a target group for light therapy: The older population is one causing the most concern in relation to blue light hazard and risk with particular concern related to Oxidative damage in the "non-replicating photoreceptor cells because they are exceptionally rich in polyunsaturated fatty acids and lipoproteins that are highly susceptible to oxidative damage and exist in an environment that is very favorable to the generation of reactive oxygen species (ROS) from the high levels of oxygen and light energy. (Sunnex Biotechnologies, 2008); (3) Additional blue light hazard due to the timing of light therapy: Light therapy is believed to be effective only during the subjective night, when melatonin levels are high. Studies show that the retina is much more sensitive to photic damage when serum melatonin levels are high. Furthermore, light therapy is often used upon awakening, when the eye is still dark-adapted. The dark-adapted eye is much more sensitive to photic damage than the eye that has previously been exposed to bright light for extended periods of time; (Sunnex Biotechnologies, 2008) (4) Additional blue light hazard potentially contributed by other medical treatments: Some applications for which light therapy is used increase the risk of retinal damage. For example, some studies suggest that light therapy can enhance and hasten the response to antidepressant medication. However, antidepressants are photosensitizing, as are many other medications, including: a) diuretics, a problem for treating geriatric chronobiological and sleep disorders b) some antibiotics, a problem for anyone who develops a bacterial infection while on light therapy c) non-steroidal anti-inflammatory drugs (NSAIDs) d) some neuroleptics; e) Heart medications and other commonly used medications and popular herbal treatments. There are additional medical factors that may increase risk of progressive ocular diseases such as AMD, including the removal of cataracts; (Sunnex Biotechnologies, 2008) and (5) Blue light therapy subverts protective mechanisms against the blue light hazard: A therapy… READ MORE

Download Full Paper

Write a New Paper for Me

Quoted Instructions for "Occupational Health and Safety and Lighting" Assignment:

“

MSc RESEARCH DISSERTATION PROPOSAL

IN

RISKS AND HAZARDS FACTORS OF BLUE BRIGHT LIGHT

RATIONALE

Should reflect the general focus of the research and be an accurate indication of the dissertation content. ie; what issue or issues sre being investigated,Why are these issues worthy of investigation , why is the research being carried out, Rationale should be properly referenced

AIM OF THE DISSERTATION

To Research that ultra***** (UV) and blue light rays may be harmful to those of us with retinal disease, in particular risk and hazards of working with blue light while marketers tell us that lamps with enhanced UV will help us to see better and stay healthier.

OBJECTIVES OF THE DISSERTATION

The objective of this study is to examine (Three or four objectives should be sufficient)

HYPOTHESIS

A statement that clearly established the purpose of research (but do ask a question in the hypothesis) A single sharp and specific sentence

METHODOLOGY

An explanation of how Data will be collected and why

Alternative methodology should be discussed

Justification of selected methodogy should be given

SUMMARY

References:

1 Berson DM, Dunn FA, Takao M. 2002 Phototransduction by retinal ganglion cells that set the circadian clock. Science 295: 1070-1073

2 Hattar S, Liao HW, Takao M, Berson DM, Yau KW. 2002. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity.Science 295: 1065-1070.

3 Menaker M. Circadian rhythms. Circadian photoreception. Science 2003;299:213-4.

4 Wee R, Van Gelder RN. Sleep disturbances in young subjects with visual dysfunction. Ophthalmology 2004;111:297-303.

5 Van Gelder RN. Blue light and the circadian c lock. Br J Ophthalmol 2004;88:1353.

6 Sparrow JR, Zhou J, Ben-Shabat S, et al. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 2002;43:1222*****“7.

7 Boulton M, Rozanowska M, Rozanowski B. Retinal photodamage. J Photochem Photobiol B 2001;64:144*****“61.

8 Rozanowska M, Jarvis-Evans J, Korytowski W, et al. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 1995;270:18825*****“30.

9 Schutt F, Davies S, Kopitz J, et al. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 2000;41:2303*****“8.

10 Suter M, RemÃ© C, Grimm C, et al. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem 2000;275:39625*****“30.

11 Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2000;41:1981*****“9.

12 Sparrow JR, Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 2001;42:1356*****“62.< BR>

13 Rozanowska M, Korytowski W, Rozanowski B, et al. Photoreactivity of aged human RPE melanosomes: a comparison with lipofuscin. Invest Ophthalmol Vis Sci 2002;43:2088*****“96.

14 Sparrow JR, Zhou J, Cai B. DNA is a target of the photodynamic effects elicited in A2E-laden RPE by blue-light illumination. Invest Ophthalmol Vis Sci 2003;44:2245*****“51.

15 Sparrow JR. Therapy for macular degeneration: insights from acne. Proc Natl Acad Sci USA 2003;100:4353*****“4.

16 Rozanowska et al Blue light-induced singlet oxygen generation by retinal lipofuscin in non-polar media. Free Radic Biol Med. 1998 May;24(7-8):1107-12.

17 Rozanowska M et al. Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem. 1995 Aug 11; 270(32): 18825-30.

18 Pawlak et al.Action spectra for the photoconsumption of oxygen by human ocular lipofuscin and lipofuscin extracts. Arch Biochem Biophys. 2002 Jul 1;403(1):59-62.

19 Verma L, Ven*****sh P, Tewari H. Phototoxic retinopathy. Ophthalmology Clinics of North America. 2001;14(4): 601-609.

20 American Conference of Governmental Industrial Hygienists. Threshold limit values for chemical substances physical agents: biological exposure indices. Cincinnati: ACGIH, 1997.

21 International Commission on Non-Ionizing Radiation Protection. Guidelines on limits of exposure to broad-band incoherent optical radiation (0.38 to 3

microM). Health Phys 1997;73:539*****“54.

22 Sliney DH, Bitran M. The ACGIH action spectra for hazard assessment: The TLV*****s. In: Matthes R, Sliney DH, ed. Measurements of optical radiation hazards. Oberschleissheim, Germany: International Commission on Non-Ionizing Radiation Protection (ICNIRP 6/98) and CIE (x016- 1998), 1998:241*****“29.

23 Kremers JJ, van Norren D. Two classes of photochemical damage of the retina. Lasers Light Ophthalmol 1988;2:41*****“52.

24 Sliney DH, Wolbarsht ML. Safety with lasers and other optical sources: a comprehensive handbook. New York: Plenum Press, 1980.

25 Kremers JJ, van Norren D. Retinal damage in macaque after white light exposures lasting ten minutes to twelve hours. Invest Ophthalmol Vis Sci 1989;30:1032*****“40.

26 Van Norren D, Schellekens P. Blue light hazard in rat. Vis Res 1990;30:1517*****“20.

27 Rapp LM, Smith SC. Morphologic comparisons between rhodopsinmediated and short-wavelength classes of retinal light damage. Invest Ophthalmol Vis Sci 1992;33:3367*****“77.

28 American Conference of Governmental Industrial Hygienists. Threshold limit values for chemical substances physical agents: biological exposure indices. Cincinnati: ACGIH, 1997.

29 International Commission on Non-Ionizing Radiation Protection. Guidelin es on limits of exposure to broad-band incoherent optical radiation (0.38 to 3 microM). Health Phys 1997;73:539*****“54.

30 Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci 1983;24:285*****“7.

31 Pautler EL, Morita M, Beezley D. Hemoprotein(s) mediate blue light damage in the retinal pigment epithelium. Photochem Photobiol 1990;51:599*****“605.

32 Saari JC, Garwin GG, Van Hooser JP, et al. Reduction of all-trans-retinal limits regeneration of visual pigment in mice. Vis Res 1998;38:1325*****“33.

33 Grimm C, RemÃ© CE, Rol PO, et al. Blue Light&# 146; s effects on rhodopsin: photoreversal of bleaching in living rat eyes. Invest Ophthalmol Vis Sci 2000;41:3984*****“90.< BR>

34 Grimm C, Wenzel A, Williams T, et al. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Inve st Opht halmo l Vis Sci 2001;42:497*****“505.

35 Mainster MA. Light and macular degeneration: a biophysical and clinical perspective. Eye 1987;1(Pt 2):304*****“10.

36 Feeney L, Berman ER. Oxygen toxicity membrane damage by free radicals. Invest Ophthalmol 1976;15:789*****“92.

37 Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995;62(Suppl):1448*****“61.

38 Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye 1995;9(Pt 6):763*****“71.

39 RemÃ© C, Reinboth J, Clausen M, et al. Light damage revisited: converging evidence, diverging views? Graefes Arch Clin Exp Ophthalmol 1996;234:2*****“11.

40 Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45:115*****“34.

41 Robison WG, Kuwabara T, Bieri JG. The roles of vitamin E and unsaturated fatty acids in the visual process. Retina 1982;2:263*****“81.

42 Marshall J. The aging retina: physiology or pathology. Eye 1987;1(Pt 2):282*****“95.

43 Mainster MA. Light and macular degeneration: a biophysical and clinical perspective. Eye 1987;1(Pt 2):304*****“10.

44 Hunyor AB. Solar retinopathy: its significance for the aging eye and the younger pseudophakic patient. Aust N Z J Ophthalmol 1987;15:371*****“5.

45 Roberts JE. Ocular phototoxicity. J Photochem Photobiol B 2001;64:136*****“43.

46 Bernstein PS, Zhao DY, W int ch SW, et al . Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular de gener ation patients. Ophthalmology 2002;109:1780*****“7.

47 Mainster MA. Solar retinitis, photic maculopathy and the pseudophakic eye. J Am Intraocul Implant Soc 1978;4:84*****“6.

48 Ts*****o MO, La Piana FG, Appleton B. The human fovea after sungazing. Trans Am Acad Ophthalmol Otolaryngol 1974;78:OP*****“677.

49 Marshall J. aging changes in human cones. Acta XXIII Concilium Ophthalmologicum (Kyoto) 1978;1:375*****“8.

50 Borges J, Li ZY, Tso MO. Effects of repeated photic exposures on the monkey macula. Arch Ophthalmol 1990;108:727*****“33.

51 Liu IY, White L, LaCroix AZ. The association of age-related macular degeneration and lens opacities in the aged. Am J Public Health 1989;79:765*****“9.

52 Taylor HR, Munoz B, West S, et al. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc 1990;88:163*****“73, discussion 173*****“8.

53 Taylor HR, West S, Munoz B, et al. The long-term effects of visible light on the eye. Arch Ophthalmol 1992;110:99*****“104.

54 Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 1993;111:514*****“8.

55 Darzins P, Mitchell P, Heller RF. Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology 1997;104:770*****“6.

56 Cruickshanks KJ, Klein R, Klein BE, et al. Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001;119:246*****“50.

57 Delcourt C, Carriere I, Ponton-Sanchez A, et al. Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liees a l*****Age (POLA) study. Arch Ophthalmol 2001;119:1463*****“8.

58 McCarty CA, Mukesh BN, Fu CL, et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 2001;119:1455*****“62.

59 Mellerio J. Light Effects on the Retina Principles and Practice Of Ophthalmology Chapter 116 Eds. Albert D M, Jakobiek F A, Saunders W B. Philadelphia, 1994.

60 Guidelines on Limits of Exposure to Broad-Band Incoherent Optical Radiation (0.38 to 3Âµm). The International Commission on Non-Ionizing Radiation Protection. Health Physics Vol. 73, No 3, pp 539-554, 1997.

61 Jackson GR, Owsley C, Cordle EP, et al. Aging and scotopic sensitivity. Vi Res 1998;38:3655*****“62.

62 Jackson GR, Owsley C, McGwin G Jr. Aging and dark adaptation. Vis Res 1999;39:3975*****“82.

63 CVRL Color & Vision database at the Institute of Ophthalmology in London. Updated: November 20th, 2003.

64 Grimm C, et al. Rhodopsin-Mediated Blue-Light Dam age to the rat Retina: Effect of Photoreversal of Bleaching. Invest Ophthalmol Vis Sci 2001 Feb;42(2):497-50.

65 Wihlmark U, Wrigstad A, Roberg K, Nilsson S, Brunk U. Lipofuscin Accumulation in Cultured Retinal Pigment Epithelial Cells Causes Enhanced Sensitivity to Blue Light Irradiation. Free Radical Biol. Med. (1997) 22, 1229-1234.

66 Kremers JJ, van Norren D. Two classes of photochemical damage of the retina. Lasers Light Ophthalmol 1988;2:41-52.

67 Kremers JJ, van Norren D. Retinal damage in macaque after white light exposures lasting ten minutes to twelve hours. Invest Ophthalmol Vis Sci 1989;30:1032-40.

68 Ham WT, Jr., Mueller HA, Sliney DH. Retinal sensitivity to damage from short wavelength ligh t. Nature 1976;260:153-5.

69 Ham WT, Jr., Ruffolo JJ, Jr., Mueller HA, Guerry D, 3rd. The nature of retinal radiation damage: dependence on waveleng th, po wer level and exposure time. Vision Res 1980;20:1105-11.

70 Threshold limit values for chemical substances physical agents: biological exposure indices. Cincinnati: American Conference of Governmental Industrial Hygienists; 1997.

71 Abbott A. Restless nights, listless days. Nature 2003;425:896-8.

72 Magnusson A, Boivin D. Seasonal affective disorder: an overview. Chronobiol Int 2003;20:189-207.

73 Hernandez-AndrÃ©s J, Romero J, Nieves JL. Color and spectral analysis of daylight in southern Europe. J. Opt. Soc. Am. Vol. 18, No. 6, pp 1325-1335, June 2001.

74 Mumford, R. Improving visual efficiency with selected lighting. Journal of Optometric Visual Development, Vol. 33, No. 3, Fall 2002.

75 Glass P. Light and the developing retina. Documenta Ophthalmologica. 1990;74(3):195-203.

76 Kini M, Leibowitz H, Colton T, Nickerson R, Ganley J, Dawber T. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol. 1978;85(1):28-34.

77 Sliney D. Ocular injury due to light toxicity. International Ophthalmology Clinics. 1988;23(3) :246-250.

78 E.M. Gasyna, K.A. Rezaei, W.F. Mieler, K.A. Rezai. Blue Light Induces Apoptosis in Human Fetal Retinal Pigment Epithelium. Ophthalmology & Visual Science, University Chicago, Chicago, IL.

79 K.A. Rezai, E.M. Gasyna, K.A. Rezaei, W.F. Mieler. AcrySof Natural Filter Decreases the Blue Light Induced Apoptosis in Human Retinal Pigment Epithelium. Ophthalmology & Visual Science, University of Chicago, Chicago, IL.

80 M.Hammer, S.Richter, K.Kobuch, D.Schweitzer. Lipofuscin Accumulation in an Organotypic Perfusion Culture of Porcine Fundi Under Oxidative Stress and Blue Light Irradiation. Department of Ophthalmology, Univ. of Jena, Jena, Germany; Department of Ophthalmology, Univ. of Regensburg, Jena, Germany.

81 J.R. Sparrow, S.Kim, K.Nakanishi, Y.Itagaki. Studies of the Photooxidation of A2E and Its Precursor A2-PE. Department of Ophthalmology, Department of Chemistry, Columbia University, New York, NY

CIS 92-1346

McKinlay A.F., Whillock M.J., Meulemans C.C.E.: Ultra***** radiation and blue-light emissions from spotlights incorporating tungsten halogen lamps.HMSO Books, P.O. Box 276, London SW8 5DT, United Kingdom, July 1989. 13p. Illus. 6 ref. Price: GBP 4.00. In English. (58289).

CIS 91-130

Wolf C., Pospischil M., Petzi D.H., Petrak R.: Bronchial hyperreactivity in foundry workers. Zentralblatt fÃ¼r Arbeitsmedizin, Arbeitsschutz, Prophylaxe und Ergonomie, 1988, Vol.38, No.9, p.279-285. Illus. 13 ref. In German. (55406).

CIS 88-299

Kordukova L.V.: Colour vision of workers under non-actinic lighting. Gigiena i sanitarija, Apr. 1986, No.4, p.86-87. 14 ref. In Russian. (48927).

CIS 87-1059

Okuno T.: Measurement of blue-light effective radiance of welding arcs. Industrial Health, 1986, Vol.24, No.4, p.213-226. Illus. 3 ref. In English. (48092).

CIS 86-1864

Althouse R., Attfield M., Kellie S.: Use of data from x-ray Screening Program for coal workers to evaluate effectiveness of 2mg/m3 coal dust standard. Journal of Occupational Medicine, Aug. 1986, Vol.28, No.8, p.741-745. Illus. 7 ref. In English. (47017).

CIS 85-278

Soutar G.N., Weaver J.R.: Biorhythms and the incidence of industrial accidents. Journal of Safety Research, Winter 1983, Vol.14, No.4, p.167-172. Illus. 16 ref. In English. (43171).

CIS 84-392

Rockwell R.J., Moss C.E.: Optical radiation hazards of laser welding processes - Part 1: Neodymium-YAG laser. American Industrial Hygiene Association Journal, Aug. 1983, Vol.44, No.8, p.572-579. Illus. 17 ref. In English. (41534).

CIS 83-982

Sliney D.H.: Biohazards of ultra*****, visible and infrared radiation. Journal of Occupational Medicine, Mar. 1983, Vol.25, No.3, p.203-206. Illus. 14 ref. In English. (39897).

CIS 83-691

Nonionizing radiations - Current issues and controversies: A minisymposium. Journal of Occupational Medicine, Feb. 1983, Vol.25, No.2, p.95-111. Illus. 61 ref. In English. (39558).

CIS 82-135

Hardy J.K., Strecker D.T., Savariar C.P., West P.W.: A method for the personal monitoring of hydrogen sulfide utilizing permeation sampling. American Industrial Hygiene Association Journal, Apr. 1981, Vol.42, No.4, p.283-286. Illus. 17 ref. In English. (36885).

*****

How to Reference "Occupational Health and Safety and Lighting" Term Paper in a Bibliography

“Occupational Health and Safety and Lighting.” A1-TermPaper.com, 2008, https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419. Accessed 6 Jul 2024.

Occupational Health and Safety and Lighting (2008). Retrieved from https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419

A1-TermPaper.com. (2008). Occupational Health and Safety and Lighting. [online] Available at: https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419 [Accessed 6 Jul, 2024].

”Occupational Health and Safety and Lighting” 2008. A1-TermPaper.com. https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419.

”Occupational Health and Safety and Lighting” A1-TermPaper.com, Last modified 2024. https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419.

[1] ”Occupational Health and Safety and Lighting”, A1-TermPaper.com, 2008. [Online]. Available: https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419. [Accessed: 6-Jul-2024].

1. Occupational Health and Safety and Lighting [Internet]. A1-TermPaper.com. 2008 [cited 6 July 2024]. Available from: https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419

1. Occupational Health and Safety and Lighting. A1-TermPaper.com. https://www.a1-termpaper.com/topics/essay/risk-hazard-factors/5690419. Published 2008. Accessed July 6, 2024.

Related Term Papers: